Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K/Akt signaling pathway.
Year: 2020
Type: article
Abstract: BACKGROUND: 5-Fu resistance is a major obstacle in the treatment of malignant tumors. Therefore, combination therapy is employed to overcome this limitation. Since it was demonstrated that emodin could resensitize breast cancer to 5-Fu treatment, we aimed to investigate if emodin could reverse 5-Fu resistant colorectal cancer (CRC) in the current study. METHODS: . RESULTS: study indicated that emodin could notably reverse 5-Fu resistance in CRC xenograft. CONCLUSION: . Thus, this finding might provide a molecular basis for treating 5-Fu resistant CRC.
Source: PubMed Central
Authors: Tonghu Li, Wenjun Si, Jiameng Zhu, Li Yin, Chongyang Zhong
Language: English
Subfield: Plant Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3033244365
